Post-transcriptional control of type 2 inositol 1,4,5-trisphosphate receptor (InsP3R2) by microRNA during cardiac hypertrophy
Lead Research Organisation:
Babraham Institute
Department Name: UNLISTED
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
Technical Summary
The beating of the heart as it pumps blood around the body is induced by an increase in the amount of calcium in its muscle cells. This increase in calcium is brought about through the entry of calcium into the cell from the extracellular space, which then causes release of calcium from calcium stores in the cell. The movement of calcium within the cell occurs through channel proteins, which span the outer membrane of the cell and the membranes that bound the intracellular calcium stores. Following the induction of contraction of the cardiac muscle cells, relaxation is then brought about by the action of energy consuming pumps, which transport calcium back into the stores and out of the cell. This project focuses upon the regulation of expression of an intracellular calcium channel called the IP3R in the muscle cells of the heart that plays a relatively minor role in regulation of contraction in the young healthy heart. With the onset of disease or ageing, the abundance of this channel is increased causing extra calcium increases in the cell, which may induce arrhythmias or inappropriate cardiac growth. Both of these effects can lead to heart failure and death. The mechanism by which we consider that the expression of the IP3R is regulated is through a small fragment of RNA called a microRNA. Our preliminary evidence suggests that the amount of this microRNA is decreased by calcium release from the IP3R. Due to the decrease in the microRNA, which normally suppresses IP3R expression, IP3R expression is allowed to increase. As such, it appears that the IP3R controls its own abundance through calcium and microRNA abundance.
Planned Impact
unavailable
Organisations
- Babraham Institute (Lead Research Organisation)
- Cincinnati Children's Hospital Medical Center (Collaboration)
- University of Oslo (Collaboration)
- University of Wurzburg (Collaboration)
- Institute of Genetic and Biomedical Research (Collaboration)
- University of Oxford (Collaboration)
- RIKEN (Collaboration)
- University of Texas Southwestern Medical Center (Collaboration)
Publications
Bootman MD
(2011)
Atrial cardiomyocyte calcium signalling.
in Biochimica et biophysica acta
Drawnel FM
(2013)
The role of the paracrine/autocrine mediator endothelin-1 in regulation of cardiac contractility and growth.
in British journal of pharmacology
Drawnel FM
(2012)
Mutual antagonism between IP(3)RII and miRNA-133a regulates calcium signals and cardiac hypertrophy.
in The Journal of cell biology
Fearnley CJ
(2011)
Calcium signaling in cardiac myocytes.
in Cold Spring Harbor perspectives in biology
Roderick HL
(2013)
Inositol 1,4,5-trisphosphate receptors: "exciting" players in cardiac excitation-contraction coupling?
in Circulation
Thul R
(2012)
Subcellular calcium dynamics in a whole-cell model of an atrial myocyte.
in Proceedings of the National Academy of Sciences of the United States of America
Tingare A
(2013)
Epigenetics in the heart: the role of histone modifications in cardiac remodelling.
in Biochemical Society transactions
| Description | calcium increases inside the muscle cells of the heart is important for heart function. One way by which calcium is increased in heart cells is by release from intracellular reservoirs via IP3 receptor channels. We have shown that this way of generating a calcium signal can cause arrhyhtmia and cardiac growth. in this project, we found that calcium release via this channel also regulated the amount of a small microRNA in cells called miR-133. Others have shown that this microRNA ordinarily inhibits cardiac growth. We found that this microRNA also put a break on the amount of IP3 receptor channels in a cells. We also found that calcium from the IP3R reduced the amount of the microRNA. Thus, by reducing miR-133 expression, IP3 receptors could control their own expression and as a consequence how they affected cardiac function. |
| Exploitation Route | by targeting the interaction between the microRNA and IP3 receptors, others may find ways to control cardiac arrhythmia and cardiac growth - possibly killing two birds with one stone. |
| Sectors | Pharmaceuticals and Medical Biotechnology |
| URL | http://jcb.rupress.org/content/199/5/783 |
| Description | Odysseus FWO |
| Amount | € 837,974 (EUR) |
| Funding ID | 90663 |
| Organisation | Research Foundation - Flanders (FWO) |
| Sector | Charity/Non Profit |
| Country | Belgium |
| Start | 09/2014 |
| End | 09/2019 |
| Description | Project Grant |
| Amount | € 472,485 (EUR) |
| Funding ID | G08861N |
| Organisation | Research Foundation - Flanders (FWO) |
| Sector | Charity/Non Profit |
| Country | Belgium |
| Start | 01/2016 |
| End | 12/2019 |
| Description | Catalucci |
| Organisation | Institute of Genetic and Biomedical Research |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Analysis of effect of micro RNA on heart growth |
| Collaborator Contribution | Provision of hearts from mice injected with miRNA inhibitor. |
| Impact | 23166348 |
| Start Year | 2011 |
| Description | Conway |
| Organisation | University of Oxford |
| Department | Department of Chemistry |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | USe and testing of cell permeant IP3 analogues |
| Collaborator Contribution | Provision of Cell permeant IP3 analogues |
| Impact | 23166348 20106523 19934645 19549843 19250908 18407350 18250332 17692540 17585817 17574672 16882691 16814379 15561771 15263017 14685260 12767897 |
| Description | MIkoshiba |
| Organisation | RIKEN |
| Department | RIKEN Brain Science Institute |
| Country | Japan |
| Sector | Public |
| PI Contribution | Analysis of tissue from itpr2 KO animals Use of IP3R2 monoclonal Antibody |
| Collaborator Contribution | Provision of IP3R2 monoclonal antibody. Provision of heart tissue from IP3R2 KO animals |
| Impact | Publication in JCB: 23166348 Publication in Mol Cell: 19250908 |
| Description | Molkentin |
| Organisation | Cincinnati Children's Hospital Medical Center |
| Department | Department of Pediatrics |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Analysed the mice |
| Collaborator Contribution | The collaborator provided hearts from control and aortically constricted mice transgenic for the IP3R Ligand binding domain and for type 2 IP3 receptors. |
| Impact | Publication in Journal of Cell Biology in 2012 23166348 |
| Start Year | 2011 |
| Description | Norway Rats |
| Organisation | University of Oslo |
| Department | Institute for Experimental Medical Research |
| Country | Norway |
| Sector | Academic/University |
| PI Contribution | Analysis of Cardiac Myocyte proteome, transcriptome and epigenome. |
| Collaborator Contribution | Provision and phenotyping of hearts hypertrophic due to exercise, aortic banding or ageing. |
| Impact | Publication in JCB in 2012 27893464 23166348 |
| Start Year | 2009 |
| Description | Ritter |
| Organisation | University of Wurzburg |
| Country | Germany |
| Sector | Academic/University |
| PI Contribution | Analysis of Cardiac tissue from aortically constricted mice. Analysis of effect of cell permeant peptide that prevents calcineurin nuclear import upon NFAT accumulation in the nucleus. |
| Collaborator Contribution | Provision of tissue from surgically prepared mice. Provision of cell permeant peptide. Provision of GFP-tagged calcineurin expression vectors. |
| Impact | Publication in Mol Cell: 19250908 Publication in PNAS: 19549843 |
| Start Year | 2007 |
| Description | UT SW |
| Organisation | University of Texas Southwestern Medical Center |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Analysis of Tissue from miR-133 DKO animals |
| Collaborator Contribution | Provision of tissue and mRNA from miR-133 double knockout animals |
| Impact | Publication in JCB in 2012: 23166348 |
| Start Year | 2010 |
| Description | 2. September 2013. Cambridge-Yale Cardiovascular Meeting, Yale, USA |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Type Of Presentation | Keynote/Invited Speaker |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Interacted with clinicians and scientists from Yale and Cambridge 50 attendees at meeting. Useful interactions made that may progress to formal collaborations. |
| Year(s) Of Engagement Activity | 2013 |
| Description | 3. June 2013. Calcium Signalling Gordon Research Conference. Il Ciocco. Italy |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Type Of Presentation | Keynote/Invited Speaker |
| Geographic Reach | International |
| Primary Audience | Other academic audiences (collaborators, peers etc.) |
| Results and Impact | 200 Participants. Valuable interactions subsequent |
| Year(s) Of Engagement Activity | 2013 |
| Description | Invited Speaker - Biochemical Society meeting 2014 |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Talk provoked interest and discussions. Possible collaborations initiated |
| Year(s) Of Engagement Activity | 2014 |
